Culture and drug susceptibility testing among previously treated tuberculosis patients in the Dominican Republic, 2014.
Rev Panam Salud Publica
; 39(1): 60-64, 2016 Jan.
Article
em En
| MEDLINE
| ID: mdl-27754535
ABSTRACT
Multidrug-resistant tuberculosis (MDR-TB) is a major public health concern that threatens global progress toward effective TB control. The risk of MDR-TB is increased in patients who have received previous TB treatment. This article describes the performance of culture and drug susceptibility testing (DST) in patients registered as previously treated TB patients in the Dominican Republic in 2014, based on operational research that followed a retrospective cohort design and used routine program data. Under the current system of TB culturing and DST, the majority of patients with previously treated TB do not undergo DST, and those who do often experience considerable delay in obtaining their results. The lack of DST and delay in receiving DST results leads to underestimation of the number of MDR-TB cases and hinders the timely initiation of MDR-TB treatment.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tuberculose
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Humans
País como assunto:
Caribe ingles
/
Dominica
/
Republica dominicana
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article